Skip to main content

Aung Naing, MD, FACP

Professor
Department of Investigational Cancer Therapeutics
Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, TX

Authored Items

Best Practices: Immune-Related Adverse Event Management in Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
By Amanda L. Brink, DNP, APRN, FNP-BC, AOCNP; Aung Naing, MD, FACP
Best Practices: Immune-Related Adverse Event Management in Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
Read More ›